Skip to main content
. 2019 Mar 1;9:3235. doi: 10.1038/s41598-019-39594-4

Figure 4.

Figure 4

Mutation burden is associated with a unique immune and clinical profile. (a) High mutation burden was associated with an immune signature that includes increased expression of genes related to cytolytic and interferon-γ signaling. (b) A volcano plot shows differential mRNA expression in low versus high mutation tumors (Student’s t-test with FDR-adjusted p-values). Unique immune signatures were associated with (c) neoantigen load and (d) immunophenotypic group. (e) Mutation burden was not associated with significant differences in overall and disease-free survival. (f) High neoantigen burden was not associated with overall survival, but did lead to worse disease-free survival (g) Presence of DNA repair gene variants did not affect overall or disease-free survival. Kaplan-Meier plots shown, **p < 0.01 based on log-rank test.